ABSTRACT: To determine the role of the hormone prolactin and its receptor on the differentiation, growth, and metabolic activity of cells of bone marrow origin, prolactin receptor expression was assessed in bone marrow stromal cells. Using reverse transcription -polymerase chain reaction, BMS2 cells, a bone marrow stromal cell line, were shown to express prolactin receptors following adipocyte differentiation, using three different adipocyte-differentiation protocols. Primary bone marrow stromal cells also show a dose-dependent increase in prolactin receptor expression following treatment with adipogenic agonists. That prolactin receptor expression is inducible upon adipocyte differentiation was contirmed using a preadipocyte cell line 3T3 -Ll. Further, prolactin receptor parallels lipoprotein lipase gene expression in 3T3-Ll cells. These results suggest that prolactin and its receptor may play a role in differentiation and/or metabolism of pre-adipocytes and adipocytes.
*To whom correspondence should be addressed.
ABSTRACT: To determine the role of the hormone prolactin and its receptor on the differentiation, growth, and metabolic activity of cells of bone marrow origin, prolactin receptor expression was assessed in bone marrow stromal cells. Using reverse transcription -polymerase chain reaction, BMS2 cells, a bone marrow stromal cell line, were shown to express prolactin receptors following adipocyte differentiation, using three different adipocyte-differentiation protocols. Primary bone marrow stromal cells also show a dose-dependent increase in prolactin receptor expression following treatment with adipogenic agonists. That prolactin receptor expression is inducible upon adipocyte differentiation was contirmed using a preadipocyte cell line 3T3 -Ll. Further, prolactin receptor parallels lipoprotein lipase gene expression in 3T3-Ll cells. These results suggest that prolactin and its receptor may play a role in differentiation and/or metabolism of pre-adipocytes and adipocytes.
Prolactin (PRL) is a peptide hormone produced mainly in the anterior pituitary but is also synthesized in extrapituitary sites (1) . PRL regulates many physiological processes and is responsible for stimulating growth and/or differentiation in numerous tissues types, including mammary epithelium, ovary, prostate, B and T lymphocytes, and macrophages (2). PRL exerts its effects through its receptor (PRL-R) which belongs to the hematopoietim cytokine receptor superfamily. PRL-R exists in three distinct forms as a result of alternative splicing of 3' exons (short, Nb2, long), but the long form is most abundant in lymphohematopoietic cells (3). The binding of PRL to its receptor causes a cascade of intracellular events. including the activation of JAKZ, Stat 1, Stat 3, Stat 5, raf, p59fyn, and MAP kinase pathways (2,4). These events, in turn, lead to specific patterns of gene transcription dependent on cell type. The biological outcome of PRL on a particular target tissue is dependent upon the cell lineage and its stage in development.
PRL-R is expressed ubiquitously in lymphoid and hematopoietic cells. Many laboratories, including ours, have demonstrated the presence of PRL-R on immune function cells, such as T and B lymphocytes, macrophages, as well as thymus, spleen and bone marrow (BM) (3,5,6). Interestingly, greater than 90% of murine BM cells express high levels of PRL-R by flow cytometry (6). BM contains a heterogeneous population of cells which can be divided into two subgroups: lympho-hematopoietic and stromal (7 These results suggest that PRL may play a role in adipocyte differentiation as well as in pre-adipocyte metabolism.
MATERIALS AND METHODS
Cell Culture Conditions and Trtwtments. Murine BMS2 BM stromal cells were plated and induced with adipogenic differentiation medium supplemented with either 0.25% DMSO (vehicle), 5 FM BRL49653 (BRL), 25 pM pioglitazone (PIO) (BRL and PI0 were a generous gift of Dr. David C. Morris, GlaxoiWellcon~e), or MHI (5 X I@' M hydrocortisone, 500 pM methylisobutylxanthine, 60 pM indomethacin) as previously described (8). 3T3-Ll cells (ATCC CCL92.1) were induced at confluence to differentiate with DMII (1 @I dexamethasone, 500 pM nletllylisobutylxanthinr, 60 pM indomsthacin, 5 &ml insulin in 0 1 % DMSO). Total RNA was prepared (8) on the indicated days following adipogenic induction. Nb2 T lymphoma subclone line 11C was stirnulzted with 10 ngiml ovine PRL (Hormone Distribution Program, National Institutes of Health) and 10 @ml cycloheximide as previously described (9). Primary bone marrow stromal cells were derived as previously described (8) and induced to differentiate with BRL or PIO.
RT-PCR Condilions. cDNA was prepared from 5 pg of total RNA (BMSZ, 3T3-Ll, primaty stromal stromal cells) as previously described (8). One pg Nb2 total RNA were reverse transcribed as described previously (5). Primers used for PRL-R and Histone 3.3 (H3.3) have been previously described (5,lO). LPL primers consisted of sense 5'-GTGGTCCTGGGAGT TTGGCTCCAGATTTGACCGCC-3' and antisense 5'-GACATCTACAAAA TCAGCGTCATCAGGAGA-3'
(1 I). One PI of cDNA ( 3%) was used in a 50 pi PCR reaction containing 50 mM KCI, 10 mM Tris-HCI, (pH 9.0), 0.1% Trlton X-100, 0.2 mM each dNTP, 1 pM each primer (0.5 PM each primer for PRLR) and 1.5 mM MgClz (3.0 mM MgCI> for PRL-R). A&r a hot start at 94"C, 2.5 units of Taq polymerax (Promega) was added. The PCR conditons for PRL-R and H3.3 consisted of denaturation at 94OC for 30 s, annealing at 60°C for 60 s, extension at 72°C for 90 s, for 30 cycles followed by a final extension for 5 min at 72°C. For LPL PCQ only 20 cycles were used but the PCR times were doubled. These conditions reproducibly generated semiquantitative PCR signals that are linear over a range of RNA (1 -5 pg) and cDNA (0.5 -10 pl) inputs and PCR cycle times (20 -30 cycles) (data not shown) (5). PCR product sizes in bp: PRLQ 309; H3.3,218; and LPL, 600.
Southern Hybridiv&m'Hot PCR. For Figure 1 .4, 30% of PCR products were resolved on a 3% NuSieve 0.5% agarose gel, transfexed overnight onto Hybond-N nylon membranes (Amersham). The PRL-R and H3.3 blots were probed with a["P]deoxycytosine triphosphate (3000 Ci/nunol; DuPont NEN) Klenow-labeled pPRL-R lb (12) and H3.3 cDNA clone (a gifl from Dr. Mark Kelley. Indiana Uniwsity, Indianapolis, IN), respectively. For all other experiments, 3 X 10' cpm (approx 0.01 1nM) of $'P] ATP(6000 Ciimmol; DuPont NEN) T4 kinase-labeled sense primer was used as B tracer for amplification as described previously (5). 10% of PCR products were resolved on a 2.5% (PRL-R and H3.3) or 1% agarose gel (LPL), dried and exposed to film. The radioactivity in PCR bands was qua&t&d by den&metric scanning of autoradiogmms in QuickScan Flur-Vis (Helena, Beaumont, TX) as previously described (5) and normalized against H3.3 PCR signals.
RESULTS AND DISCUSSION
Adioocvte differentiation of bone marrow stromal cells is associated with PRL-R exuression. Approximately 92-97% of mnrine bone marrow cells express high levels of PRL-R as detected by flow cytometry (6). However, PRL-R mRNA is a low abundance message, necessitating the use of RT-PCR for its analysis (5,6,13). Two PRL-R primers were selected to span the transmembrane region of PRL-R, which will examine both long and short forms of the PRL-R mRNA (5). To examine which cells within the BM stroma express PRL-R, we first employed the murine BMS2 cell line which is capable of supporting lympho-hematopoiesis and can undergo adipocyte differentiation in culture (14). Adipocyte differentiation is accomplished by MHI treatment which stimulates the expression of various fat-specific genes, accumulation of lipid droplets and changes in cellular morphology in BMS2 cells (8,15). Untreated BMS2 did not express detectable PRL-R (Pig. 1 A, lane 2). However, the differentiation regimen resulted in strong PRL-R expression by day 3 (lane 3) which peaks by day 6 (lane 4), and declines by day 9 (lane 5). Invariant histone 3.3 (H3.3) was used as an RT and PCR control. The kinetics of PRL-R expression corresponded well with that of other fat-specific genes (8,15,16) (See Fig. 3 ). To further substantiate this correlation, thiazolidenedione compounds, members of a class of chemicals known to cause fat differentiation through interactions with orphan steroid hormone receptor PPARy, were tested for their ability to induce PRL-R expression in BMS2 cells (Fig. 1B) . Radioactive or 'hot' PCR was performed in lieu of PCR followed by Southern blotting as it is more sensitive (5). At day 6, both BRL49653 (BRL) (lane 3) and pioglitazone (PIO) (lane 4) also induced PRL-R gene expression when compared with MHI (lane 2). Three independent experiments examining the effects of BRL, PIO, and MHI on PRL-R in BMS2 cells are summarized in Fig. 1C . These results indicate that PRL-R expression is upregulated from 4 to S-fold during adipogenic differentiation in the BMS2 stromal cell line.
Adipogenic agonists induce dose-denendent exuression of PRL-R in primary BM cells. To determine if primary BM stromal cells exhibit a similar pattern of PRL-R expression, cultures of murine stromal cells were treated with varying doses of BRL, or PI0 (Fig. 2) . Both thiazolidenediones induced expression of PRL-R in primary murine BM cells in a dose-dependent manner. Comparisons showed that 5 PM BRL (lane 6) is relatively more potent as an inducer than 25 @l PI0 (lane 10). PRL-R signals were weaker due to heterogeneity in the primary BM population, but were reproducible in two independent experiments (data not shown). These data indicate that the ability to upregulate PI&R in BM stromal cells by adipogenic A. agonists occurs also in primary BM stromal cells and may represent a natural differentiation process.
3T3-Ll adipoblasts can be induced to exuress PRL-R during adiuogenesis. To investigate if the upregulation of PRL-R during adipocyte differentiation was a more general response, the preadipocyte cell line 3T3-Ll was used to examine if PRL-R expression accompanies adipocyte differentiation. 3T3-Ll cells were induced to differentiate with BRL, PIO, or Dh4I1, regimens all known to induce fat cell differentiation in this cell line (Fig. 3) . Untreated 3T3-Ll cells at day 0 (lane 1) and day 2 (lane 2) after differentiation expressed no detectable PRL-R mRNA. Low levels of PRL-R were expressed in control groups on days 4, 6, and 8 (lanes 6, 10, 14, respectively). All three adipogenic treatment regimens induced PRL-R by day 2 (lanes 3-5), with DMII being the most potent inducer of PRL-R in 3T3-Ll cells. RT-PCR for lipoprotein lipase (LPL), a gene expressed early in fat cell differentiation, was performed as a control for adipogenesis. A very low basal level of LPL was detected in untreated 3T3-Ll cells (lanes 1 and 2) as previously reported (14). LPL expression paralleled that of PRL-R, reaching a maximum at days 6-S (lanes 10-17) . These results indicate that the induction of PRL-R occurs during adipogenesis in other pre-adipocyte models, and is not limited to the cells of the bone marrow stromal compartment.
Our studies showed that PRL-R expression is induced during the process of adipocyte differentiation in a variety of cell types. Although PRL-R and LPL genes are expressed concurrently, it is not clear whether PRL stimulates LPL gene expression. Interestingly, the LPL promoter contains several GAS-like elements to which Stat factors can bind. Stat Our results offer a possible explanation in that the PRL-R is only highly expressed during early adipocyte differentiation but declines after the cells achieve the fully-differentiated state. Whether PRL regulates LPL gene expression at both the transcriptional and posttranscriptional levels (21) as observed for insulin regulation of the LPL gene (21,22), remains to be determined.
It is currently unclear what induces PRL-R expression in the bone marrow stroma, although thiazolidinediones acting through the steroid receptors mPPARy may contribute to PRL-R expression during the early stages of adipogenesis (8). The data presented here indicate that PRL-R expression may be an early marker for adipocyte differentiation, and suggest that PRL functions as a differentiation signal, operating through the strict temporally-regulated expression of PP.L-R in BM stroma. PRL-R expression in lympho-hematopoietic lineage cells are currently under investigation,
